Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Schwarz Pharma (2006)
Celltech (2004) |
| gptkbp:ceo |
gptkb:Jean-Christophe_Tellier
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:employees |
around 7,500
|
| gptkbp:focus |
neurology and immunology
|
| gptkbp:founded |
1928
|
| gptkbp:founder |
gptkb:Eugène_Schueller
|
| gptkbp:headquarters |
gptkb:Brussels,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCB Pharma
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:market |
global
|
| gptkbp:operates_in |
over 40 countries
|
| gptkbp:partnership |
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer gptkb:Amgen |
| gptkbp:products |
gptkb:Briviact
gptkb:Cimzia gptkb:Neupro |
| gptkbp:research_focus |
biologics
small molecules |
| gptkbp:revenue |
€5.1 billion (2020)
|
| gptkbp:stock_exchange |
gptkb:Euronext_Brussels
|
| gptkbp:stock_symbol |
gptkb:UCB
|
| gptkbp:subsidiaries |
gptkb:UCB_Celltech
|
| gptkbp:website |
www.ucb.com
|
| gptkbp:bfsParent |
gptkb:Lacosamide
|
| gptkbp:bfsLayer |
6
|